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In 2010, 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the US for prevention of
invasive pneumococcal disease in children. Individual-level socioeconomic status (SES) is a potential
confounder of the estimated effectiveness of PCV13 and is often controlled for in observational studies
using zip code as a proxy. We assessed the utility of zip code matching for control of SES in a post-licensure
evaluation of the effectiveness of PCV13 (calculated as [1-matched odds ratio]*100). We used a directed
acyclic graph to identify subsets of confounders and collected SES variables from birth certiﬁcates, geo-
coding, a parent interview, and follow-up with medical providers. Cases tended to be more afﬂuent than
eligible controls (for example, 48.3% of cases had private insurance vs. 44.6% of eligible controls), but less
afﬂuent than enrolled controls (52.9% of whom had private insurance). Control of confounding subsets,
however, did not result in a meaningful change in estimated vaccine effectiveness (original estimate: 85.1%,
95% CI 74.8–91.9%; adjusted estimate: 82.5%, 95% CI 65.6–91.1%). In the context of a post-licensure vaccine
effectiveness study, zip code appears to be an adequate, though not perfect, proxy for individual SES.
Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Low socioeconomic status (SES) is frequently found to be as-
sociated with poor health outcomes, despite substantial advancesaccess article under the CC BY-NC
ontrol and Prevention, 1600
k-Gelles).in prevention and treatment of disease (Phelan & Link, 2005;
Braveman, Cubbin, Marchi, Egerter, & Chavez, 2001; Janssen,
Boyce, Simpson, & Pickett, 2006). This association is concerning,
especially in the US, where substantial differences in access to
healthcare, nutritious foods, and physical activity exist between
more and less afﬂuent individuals and neighborhoods (Phelan &
Link, 2005; Braveman et al., 2001; Janssen et al., 2006; Burton,
Flannery, & Bennett, 2010; Cohen, Doyle, & Baum, 2006; Iwane,-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Spicer, Thomas, Holst, Baughman, & Farley, 2014). While no single
deﬁnition of SES is universally accepted, individual-level SES is
generally measured as a combination of income, education, and
occupation, which in turn provide surrogate measures of re-
sources, prestige, knowledge, and power (Phelan & Link, 2005;
Janssen et al., 2006; Pardo-Crespo, Narla, & Williams, 2013; Krie-
ger, Chen, Waterman, & Rehkopf, 2003; Krieger, Chen, Kosheleva,
& Waterman, 2012; Krieger, Singh, & Chen, 2015; VanderWeele &
Robinson, 2014). Race, ethnicity, and health insurance status may
also be considered markers of SES, because these factors provide
insights into access to resources, knowledge and power, and are
frequently easier to obtain for research than income or education
levels (Braveman et al., 2001; Lantz et al., 2005; Krieger, Chen,
Waterman, Rehkopf, & Subramanian, 2005; Braveman, Cubbin, &
Egerter, 2005; Williams, 1999; Shavers, 2007).
When SES is measured to control for potential confounding of
an exposure-disease relationship, most researchers will simply
match on SES or control for SES during analysis, depending on the
study design. It is paramount that the variable serve as an accurate
surrogate of the construct that one intends to measure. For ex-
ample, if neighborhood-level income is being used as a surrogate
for individual-level income level, one must be conﬁdent that this
cross-level inference is valid (Diez-Roux, Kiefe, & Jacobs, 2001;
Diez Roux, 2004).
Because SES is often clustered geographically and individual-
level data can be difﬁcult to obtain, researchers often assess SES
ecologically, for example by using neighborhood-level measures,
such as prevalence of poverty by zip code (Taber et al., 2015;
Feinglass, Rydzewski, & Yang, 2015; Agarwal, Menon, & Jaber,
2015). For example, research conducted using cases identiﬁed
through disease surveillance systems frequently uses zip code as a
proxy for individual SES. Surveillance systems generally in-
corporate addresses, but rarely include characteristics such as
personal or household income, educational attainment, or occu-
pation, which require follow-up with individual cases (Krieger
et al., 2003; Feinglass et al., 2015). Using zip code is a relatively
easy way to measure SES, but requires the assumption that zip
code is an adequate proxy for individual or household level SES
(Diez Roux, 2004; Diez Roux, Schwartz, & Susser, 2002).
One type of study in which potential confounding by SES is of
concern is post-licensure vaccine effectiveness studies, frequently
conducted after a vaccine is introduced and typically using a case-
control study design. Because both the exposure (vaccination) and
outcome (infectious disease) may be associated with SES, the po-
tential for confounding may exist and researchers therefore fre-
quently match on zip code (Iwane et al., 2013; Spicer et al., 2014;
Cutts, Orenstein, & Bernier, 1992; Hutchins, Baughman, Orr, Haley, &
Hadler, 2004; Hutchins, Jiles, & Bernier, 2004; Walker, Smith, &
Kolasa, 2014; Smith & Stevenson, 2008; Boom, Tate, & Sahni, 2010;
Whitney, Pilishvili, & Farley, 2006; Cochran et al., 2010; McTiernan,
Thomas, Whitehead, & Noonan, 1986). Zip code matching, however,
only ensures that eligible controls are similar to enrolled cases at
the zip code level. Differences may remain between the groups at
smaller area levels (i.e., census tract) or at the individual level. Thus,
even after matching on zip code, confounding by individual SES
may remain. To date, little research has explored whether matching
on zip code provides adequate control for individual SES in vaccine
effectiveness studies in the US (Boom et al., 2010; Whitney et al.,
2006; Cochran et al., 2010; Krieger et al., 2002).
We were concerned about confounding by individual SES in a
zip code-matched case-control study of 13-valent pneumococcal
conjugate vaccine (PCV13) effectiveness (Moore et al., 2016).
PCV13 was licensed for use in children in the US in February 2010
and replaced the effective, but more limited, 7-valent vaccine
(PCV7) (09PRT/8166, 2009; Centers for Disease Control andPrevention, 2010). SES, including income, educational attainment,
and related factors (e.g., asthma, smoking exposure), has been
frequently shown to be associated with both vaccination status
and risk of invasive pneumococcal disease (IPD) and is therefore of
concern as a potential confounder (Cutts et al., 1992; Hutchins
et al., 2004; Walker et al., 2014; Smith & Stevenson, 2008; Flan-
nery, Schrag, & Bennett, 2004; Wortham, Zell, & Pondo, 2014;
Smith, Nuorti, Singleton, Zhao, & Wolter, 2007). Zip code matching
was used to control for SES. The purpose of the present study was
to determine whether this approach provided adequate control for
confounding at the census tract and individual levels or if addi-
tional control of confounding was necessary.Methods
Enrollment methods
Details of the vaccine effectiveness study and results of the
primary analysis have been previously published (Moore et al.,
2016). Brieﬂy, cases of IPD were identiﬁed through the Centers for
Disease and Control and Prevention's (CDC) Active Bacterial Core
surveillance, an active population- and laboratory-based surveil-
lance system for invasive bacterial diseases in ten sites around the
US (Active Bacterial Core surveillance (ABCs), 2014). Three other
sites with similar case identiﬁcation methods were added to in-
crease numbers of cases: New York City, Los Angeles County, and
the State of Utah. Eligible case-children were identiﬁed through
routine surveillance between May 1, 2010 and May 31, 2014 who
were 2-59 months of age with a pneumococcal serotype available
(09PRT/8166, 2009). Informed consent was obtained for all en-
rolled cases and controls. Both the parent study and the current
analysis were approved by institutional review boards (IRB) at CDC
and the surveillance sites. The current analysis was also approved
by the University of North Carolina, Chapel Hill IRB.
Enrollment procedures for case and controls have been de-
scribed previously (Moore et al., 2016). Brieﬂy, study staff con-
tacted parents/guardians of case and control children via tele-
phone to obtain consent, ascertain information on factors poten-
tially related to disease, and gather contact information for vaccine
providers; providers were then asked for detailed medical and
vaccine history information (Whitney et al., 2006; Pilishvili, Zell, &
Farley, 2010). Once a case-child was enrolled, staff obtained from
local birth registries a list of 20–40 children born in the case-
child's zip code within 14 days of the case-child's birth. If four
controls could not be enrolled from within a case-child's zip code,
additional controls were obtained from adjacent zip codes. Con-
trols were then enrolled in order, starting with the control-child
whose birth date was closest to the case and then ranked alpha-
betically. At least 10 attempts to enroll a control were made at
different times of the day and on different days of the week before
moving on to the next potential control.
The main analysis excluded children who could not be located,
whose parents refused, whose vaccination history could not be
veriﬁed, who had a recurrent IPD episode (cases only), were in
foster care (controls only), had died for any reason (controls only),
or were the sibling of a previously enrolled child (controls only),
and residents of long-term care facilities. Finally, for the purposes
of this analysis, cases and controls from two surveillance sites,
Colorado and Maryland, were excluded because individual-level
birth certiﬁcate data were not available to investigators.
Identiﬁcation of confounders
To identify confounders for adjustment in our analytic model of
vaccine effectiveness, we constructed a directed acyclic graph
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bins, 1999; Hernan, Hernandez-Diaz, & Robins, 2004). DAGs, or
causal diagrams, are an increasingly utilized tool in epidemiology
for identifying variables that should be controlled for to obtain
unbiased effect estimates (Greenland et al., 1999). Brieﬂy, in-
vestigators begin by putting all variables potentially related to the
cause and effect relationship under study on a graph, connected
via unidirectional arrows showing causal relationships between
the variables. The graph enables investigators to explicitly show
assumptions about the underlying causal structure and to identify
confounding pathways that should be controlled (the “minimally
sufﬁcient subset” of confounders) (Greenland et al., 1999; Van-
derWeele & Robins, 2007). We used DAGitty.net (version 2.2)
software(Textor, Hardt, & Knuppel, 2011) to identify minimally
sufﬁcient confounding subsets for adjustment. Zip code matching
ensured that enrolled cases and eligible controls had similar ag-
gregate SES at the zip code level, but not at the census tract or at
the individual level. Our DAG included both census tract and in-
dividual SES measures to determine if zip code was an adequate
proxy (i.e., if controlling for zip code alone would block all con-
founding pathways between census tract, individual SES, and
PCV13/IPD). Multiple minimally sufﬁcient confounding subsets
were identiﬁed, with substantial overlap between them. We se-
lected one minimally sufﬁcient subset for our primary analysis
based on the completeness of the variables included (i.e., fewest
matched pairs dropped due to missing data). In addition to con-
founders identiﬁed by our DAG, we also assessed distributions of
other SES-related characteristics available from birth certiﬁcates
and at the census tract-level from the US Census Bureau's Amer-
ican Community Survey (ACS) by case-control status.
Values of confounders were identiﬁed from three sources. First,
we used the parent interview and provider follow-up to obtain
information on smoking exposure and daycare attendance (any vs.
none in the 30 days before the case-child's culture date), inﬂuenza
vaccination or infection within the previous six months, house-
hold income, primary caregiver education, insurance status at time
of IPD culture, underlying condition status (asthma, chronic lung
or heart disease, diabetes, cerebrospinal ﬂuid leak, cochlear im-
plant, sickle cell disease, congenital or acquired asplenia, HIV/AIDS,
chronic renal failure, nephrotic syndrome, malignant neoplasm,
leukemia, lymphoma, solid organ transplant, congenital im-
munodeﬁciency (Centers for Disease Control & Prevention, 2010)),
breastfeeding (ever vs. never), presence of other children in the
household, and household crowding (42 people per room) (Spi-
cer et al., 2014; Smith & Stevenson, 2008; Wortham et al., 2014;
Pilishvili et al., 2010; Zhao & Smith, 2013). Because only parents/
guardians of enrolled case- and control-children were interviewed,
these variables were not available for unenrolled control-children.
The second source of confounder information was data from
birth certiﬁcates of enrolled and unenrolled children. These vari-
ables included timing of initiation of prenatal care and gestational
age (which were used to calculate the Adequacy of Prenatal Care
Utilization Index (Kotelchuck, 1994; Kotelchuck, 1994)), maternal
race/ethnicity, maternal education, and insurance status at birth
(U.S. Standard Birth Certiﬁcate, 2014). Prenatal care, while not a
typical SES measure, is likely to be related to access to and utili-
zation of health services. Finally, eligible cases and controls were
geocoded, allowing linkage with census tract information obtained
via the ACS, which includes such neighborhood measures as in-
come, racial/ethnic distribution, and proportion living below the
poverty line, among many others (American Community Survey:
Information Guide, 2014). Of these, residence in a neighborhood
with 425% foreign born individuals was included on our DAG.Comparison groups
We explored the potential for residual confounding in two
ways, both of which compared differences between enrolled cases
and a group of controls. First, using available data on all enrolled
cases and all eligible controls (regardless of enrollment) we as-
sessed whether differences existed between the groups. If no
differences existed between enrolled cases and eligible controls,
this would indicate zip code matching theoretically controlled for
measured confounders. In other words, if the two groups were
similar, this indicates that, in the absence of selection issues,
matching on zip code resulted in controls who were exchangeable
with cases with respect to measured SES characteristics. If, how-
ever, differences between enrolled cases and eligible controls ex-
isted, this would indicate zip code matching had failed to control
for individual-level SES.
Second, we restricted our analysis to enrolled cases and en-
rolled controls, allowing us to assess how selection issues such as
failure to locate or enroll controls in the study affected our ﬁnal
study population. The meaning of the results of this step is de-
pendent on the results of the ﬁrst step. If enrolled cases were si-
milar to eligible controls and enrolled controls, this would indicate
that zip code matching was successful (i.e., enrolled cases were
similar to eligible controls) and there was no selection bias. Our
study population would therefore be exchangeable with respect to
measured SES. If, however, enrolled cases were similar to eligible
controls, but not to enrolled controls, this would indicate selection
bias. If zip code matching failed (enrolled cases were not similar to
eligible controls), any similarity between enrolled cases and en-
rolled controls would likely be due to chance.Statistical methods
Descriptive analyses of univariate distributions in cases and
controls were assessed for confounders identiﬁed in the minimally
sufﬁcient confounding subset, as well as related characteristics
available from birth certiﬁcates and geocoding. Most variables
collected from the parent interview, provider follow-up, and birth
certiﬁcates were categorical in nature and left in this form in the
initial analysis. Categories were combined for modeling purposes
when sample sizes in individual strata were too low. The results of
conditional logistic regression models with enrolled children only,
including all confounders identiﬁed in the minimally sufﬁcient
confounding subsets, were compared to the original model (rerun
without Colorado and Maryland), which included only the
matching factors of age and zip code. The exposure was receipt of
one or more doses of PCV13 at least 14 days before pneumococcal
culture (or the matched case's culture date for controls).
The primary outcome for the parent study was PCV13-type IPD,
which was also the focus of the current analysis. We used cases
caused by serotypes not included in PCV13 as negative controls.
That is, assuming no cross-reactivity with vaccine-types, vaccine
effectiveness against non-vaccine types should be zero, so a high
(or low) signiﬁcant estimate would indicate a problem with the
methods or analysis. Vaccine effectiveness is calculated as (1 –
matched odds ratio)*100% for a rare disease, such as IPD (Whitney
et al., 2006). All models were conditional logistic regression to
account for the matched design and to calculate the matched odds
ratio (with each case and its matched controls composing a single
strata). An absolute difference in the vaccine effectiveness of ﬁve
percentage points between the full and original models was con-
sidered an indication of meaningful confounding (e.g., a change
from 95% to 90% effectiveness).
Table 2
Characteristics of eligible cases and matched controls. Data come from (a) birth
certiﬁcates, (b) American Community Survey, or (c) the parent interview/medical
provider follow-up.
2 (a) Birth certiﬁcate Enrolled
cases
(n¼661)
Eligible con-
trols
(n¼12,050)
Enrolled con-
trols
(n¼2774)
Characteristic
Maternal race/ethnicity, n (%)
White, non-Hispanic 268 (46.7) 5055 (43.2) 1488 (54.7)
Black, non-Hispanic 127 (22.1) 2257 (19.3) 420 (15.4)
Hispanic 52 (9.1) 1072 (9.2) 186 (6.8)
Other, non-Hispanic 127 (22.1) 3312 (28.3) 628 (23.1)
Unknown 87 354 52
Maternal education level, n (%)
Less than high school 110 (20.2) 2516 (22.9) 420 (16.8)
High school equivalent 130 (23.9) 2905 (26.4) 529 (21.2)
Some college 146 (26.8) 2851 (26.0) 690 (27.6)
College degree or more 158 (29.0) 2714 (24.7) 857 (34.3)
Unknown 117 1064 278
Source of payment for birth, n
(%)
Private 228 (48.2) 4238 (44.9) 1120 (52.9)
Public/state 223 (47.1) 4707 (49.9) 893 (42.1)
Uninsured 8 (1.7) 232 (2.5) 41 (1.9)
Other 14 (3.0) 264 (2.8) 65 (3.1)
Unknown 188 2609 655
Adequacy of Prenatal Care
Utilization Index, n (%)
Adequate Plus 183 (34.9) 3377 (31.4) 814 (33.0)
Adequate 186 (35.5) 4130 (38.4) 972 (39.5)
Intermediate 67 (12.8) 1360 (12.6) 272 (11.0)
Inadequate 88 (16.8) 1888 (17.6) 405 (16.4)
Unknown 137 1295 311
2 (b) American Commu-
nity Survey
Not successfully geocoded,
n (%)
9 (1.4) 179 (1.5) 20 (0.7)
Median income, n (%)
r$15,000 37 (5.7) 796 (6.7) 150 (5.4)
4$15,000 to r$30,000 374 (57.4) 6802 (57.4) 1485 (53.9)
4$30,000 to r$45,000 191 (29.3) 3315 (28) 849 (30.8)
4$45,000 to r$60,000 37 (5.7) 711 (6.0) 204 (7.4)
4$60,000 13 (2.0) 232 (2.0) 66 (2.4)
Crowding, median % (IQR)
0.50 or less occupants per
room
68.2 (52.8,77) 67.1 (50.6,77) 69.3 (55,78.1)
0.51 to 1.00 occupants per
room
28.6 (20.9,38.5) 29.7 (22,38.5) 27.5 (19.8,37.4)
1.01 to 1.50 occupants per
room
2.2 (1.1,5.5) 2.2 (1.1,6.6) 2.2 (0,5.5)
1.51 to 2.00 occupants per
room
0 (0,2.2) 0 (0,2.2) 0 (0,2.2)
2.01 or more occupants per
room
0 (0,0) 0 (0,1.1) 0 (0,0)
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Enrollment
Of 1040 eligible cases, we enrolled 661 (63.6%) children. We
identiﬁed 12,305 potential controls, of whom, 255 were excluded
because they had moved out of the surveillance area by the time of
the corresponding case's IPD diagnosis and were therefore in-
eligible for enrollment. Of the 12,050 eligible controls, 2774
(23.0%) were enrolled. The primary reasons for non-enrollment
were an inability to locate/contact the parent/guardian (7,516,
81.0%) and refusal (1,600, 17.2%). In addition, 160 (1.7%) were not
enrolled for other reasons, including the lack of a vaccine history, a
language barrier, or being in foster care.
The 661 enrolled cases came from 557 zip codes and 632
census tracts (Table 1). Of the 12,050 eligible controls, the major-
ity, 8690 (72.1%), came from the same zip code as their matched
case. However, only 1250 (10.4%) came from the same census tract
as their matched case. A similar pattern was seen among enrolled
controls, with, 1921 (69.3%) coming from the same zip code as
their matched case and 271 (9.8%) coming from the same census
tract as their matched case.
Differences between enrolled cases and eligible controls
Based on birth certiﬁcate data, enrolled cases tended to have
slightly more afﬂuent mothers than eligible controls. For cases,
44.1% of mothers had no college education, compared with 49.3%
of mothers of eligible controls (Table 2). Additionally, 48.2% of
cases had private insurance at birth, compared with 44.9% of
controls. Mothers of cases and eligible controls were similarly
likely to have had at least adequate prenatal care utilization (70.4%
of cases vs. 69.8% of controls).
A similar pattern was seen for neighborhood level character-
istics. In census tracts of enrolled cases, a median of 15.4% of in-
dividuals lived below the poverty level, compared with a median
of 16.5% in census tracts of eligible controls (Table 2). In addition,
31.3% of cases came from census tracts with more than a quarter of
the population being foreign born, compared to 34.8% of eligible
controls. Median income, crowding, and income inequality (as
measured by Gini Index) were also similar between cases and
eligible controls (Table 2).
Differences between enrolled cases and controls
Unlike eligible controls, enrolled controls had a higher SES than
enrolled cases. Based on information collected during the parent
interview, 53.8% of cases came from households with incomes above
$30,000/year, compared to 62.1% of controls. Less than half (44.4%)
of cases had private insurance at the time of IPD diagnosis, vs. 52.7%
for controls. Primary caregivers of cases were slightly less likely to
have at least some college education (67.3% of cases vs. 70.6% of
controls). Enrolled controls were also more likely to have breastfed
and less likely to have an underlying condition, have attended
daycare, be passively exposed to smoking (Table 2). The birthTable 1
Number of unique zip codes and census tracts for eligible and enrolled children, by
case status and serotype of disease.
Enrolled cases Eligible controls Enrolled controls
Total N 661 12,050 2774
Unique zip codes 557 1209 577
Unique Census Tracts 632 4835 2126
Poverty, median % (IQR)
o100% of poverty level 15.4 (7.7,25.3) 16.5 (8.8,26.4) 13.2 (7.7,24.2)
100–149% of poverty level 9.9 (5.5,14.3) 9.9 (5.5,15.4) 9.9 (5.5,14.3)
Z150% of poverty level 73.7 (59.4,85.8) 72.6
(58.3,84.7)
75.9
(61.6,86.9)
Gini Index, n (%)a
0.2 to o0.3 17 (2.6) 148 (1.2) 56 (2.0)
0.3 to o0.4 255 (39.1) 4537 (38.3) 1146 (41.6)
0.4 to o0.5 325 (49.8) 6092 (51.4) 1324 (48.1)
Table 2 (continued )
2 (a) Birth certiﬁcate Enrolled
cases
(n¼661)
Eligible con-
trols
(n¼12,050)
Enrolled con-
trols
(n¼2774)
Characteristic
0.5 to o0.6 52 (8.0) 1030 (8.7) 219 (8.0)
0.6 to o0.7 3 (0.5) 48 (0.4) 9 (0.3)
0.7 to o0.8 0 0 0
Census tract is 425% for-
eign born, n (%)
204 (31.3) 4120 (34.8) 804 (29.2)
2(c) Parent interview/medical provider follow-up
Median age, months
(range)
21 (2-59) 21 (2-60)
Asthma, n (%) 128 (19.4) 321 (11.6)
Chronic condition, n (%) 51 (7.7) 32 (1.2)
Immunocompromising
condition, n (%)
111 (16.8) 82 (3.0)
Breastfeeding, n (%)
Ever breastfed 480 (73.2) 2224 (80.4)
Currently breastfed 52 (7.9) 303 (11.0)
Crowding (42 people per
bedroom)
111 (16.8) 414 (15)
Day care attendance, n (%) 313 (47.5) 957 (34.6)
Smoking exposure, n (%) 134 (20.5) 443 (16.1)
Recent inﬂuenza infection,
n (%)
20 (3.2) 25 (1)
Inﬂuenza vaccination in
last 6 months, n (%)
184 (27.8) 830 (30)
Household income, n (%)
r$15,000 166 (27.9) 474 (18.5)
4$15,000 to r$30,000 100 (16.8) 455 (17.7)
4$30,000 to r$45,000 53 (8.9) 259 (10.1)
4$45,000 to r$60,000 65 (10.9) 286 (11.1)
4$60,000 192 (32.3) 975 (38)
Refused 19 (3.2) 119 (4.6)
Unknown 66 206
Insurance type at IPD, n (%)
Private 288 (44.4) 1449 (52.7)
Public 344 (53.1) 1227 (44.7)
Uninsured 15 (2.3) 54 (2.0)
Other 0 4 (0.1)
Refused 1 (0.2) 13 (0.5)
Unknown 13 27
Race/ethnicity, n (%)
White, non-Hispanic 259 (39.4) 1368 (49.4)
Black, non-Hispanic 165 (25.1) 469 (16.9)
Hispanic 64 (9.7) 191 (6.9)
Other, non-Hispanic 169 (25.7) 739 (26.7)
Unknown 4 7
Primary caregiver educa-
tion level, n (%)
Less than high school 78 (12.0) 289 (10.6)
High school equivalent 134 (20.7) 515 (18.8)
Some college 193 (29.8) 661 (24.2)
College degree or more 243 (37.5) 1272 (46.5)
Unknown 13 37
a Measure of income inequality for a geographic area where zero indicates
absolute equality and one indicates total inequality.
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cases and controls. The two groups had a similar distribution of
prenatal care utilization (70.4% of cases vs. 72.5% of controls with
adequate or adequate plus prenatal care utilization), while cases
were slightly less likely to have had private health insurance at the
time of birth (48.2% of cases vs. 52.9% of controls).DAG analysis and adjusted models
In the main analysis, the unadjusted vaccine effectiveness
against PCV13-type disease was 86.0% (95% CI: 75.5% to 92.3%)
(Moore et al., 2016). Once we excluded the children fromMaryland
and Colorado, the original estimate (controlling for only the
matching variables) was 85.1% (95% CI: 73.8% to 91.9%), similar to
that from the main analysis. We identiﬁed four minimally sufﬁ-
cient confounding subsets. The subset including age, asthma,
breastfeeding, presence of children in the household, underlying
condition status, inﬂuenza vaccination status, household income,
insurance type at IPD diagnosis, race, smoking exposure and zip
code had the fewest missing values and was chosen for the pri-
mary analysis (Table 3). The adjusted vaccine effectiveness esti-
mate was 83.5% (95% CI: 67.3% to 91.6%). The remaining three
subsets yielded estimates of vaccine effectiveness between 81.2%
and 83.1%, with 95% CIs ranging from 55.1% to 93.6% (Table 3).
None of the vaccine effectiveness point estimates from the ad-
justed models differed by an absolute value of 5 percentage points
or more from the original model, so we used the original model as
our “ﬁnal” model. As expected, our negative control (vaccine ef-
fectiveness against non-vaccine types) yielded low point esti-
mates, with wide conﬁdence limits, all of which crossed the null
value (vaccine effectiveness¼0).Discussion
We assessed the use of zip code matching to control for in-
dividual-level SES in a matched case-control study of the vaccine
effectiveness of PCV13 in children less than ﬁve years of age in the
US. We found enrolled cases to be slightly more afﬂuent than
eligible controls, but slightly less afﬂuent than enrolled controls, as
measured by census tract and individual SES variables from parent
interviews, provider follow-up, and birth certiﬁcates. Adjustment
for these variables, however, did not substantially change our es-
timate of vaccine effectiveness, indicating that zip code matching
was an adequate proxy for individual SES in our study and that our
previously-published unadjusted estimates should be valid with
respect to individual SES.
We assessed a number of SES-related variables beyond those
identiﬁed as confounders in our DAG. SES is a general term en-
compassing numerous aspects of an individual or neighborhood
and cannot be perfectly measured by any one or any series of
characteristics. The exact mechanism(s) by which SES is related to
IPD risk is unknown, but clearly multifaceted (i.e., related to con-
ventional SES measures such as household income and crowding,
but also to less conventional measures, such as smoking exposure
and asthma). Therefore, the potential for unmeasured confounding
could be substantial, so exploring a broader subset of SES char-
acteristics is ideal.
Our ﬁnding that enrolled cases were slightly more afﬂuent than
eligible controls was expected, given that enrolled cases are the
subset of the population of eligible cases we were able to locate and
enroll, whereas eligible controls represent the entire area. More
afﬂuent individuals may be more likely to have landlines or retain a
single telephone number over time (making them easier to reach)
and may have increased use of and trust in the medical system
(making them more likely to agree to enrollment) (Wireless Sub-
stitution, 2014; Klosky et al., 2009; Kramer, Wilkins, & Goulet,
2009). The differences indicate that (as expected) zip code may not
be a perfect proxy for individual SES in our population. However,
the differences did not have a substantial effect on our estimate of
vaccine effectiveness. Thus, zip code may sufﬁce for matching
purposes for SES, especially if, as in this study, data are available to
assess differences and adjust for or interpret results appropriately.
Table 3
Comparison of results of original model vs. models adjusted for minimally sufﬁcient subsets (MSS) for effectiveness against PCV13-type and non-PCV13-type disease.a
Modelb VE (95% CI) PCV13-type dis-
cordant pairsc
Absolute % difference in
VE vs. unadjusted for
PCV13-typesPCV13 NVTa
Original (unadjusted, except for matching factors) 85.1 (73.8–91.9%) 21.4 (18.8–47.7%) 96 Referent
Primary minimally sufﬁcient confounding subset
MSS1¥: other children in household, inﬂuenza vaccination in the year
before culture
83.5 (67.3–91.6%) 32.6 (12.7–59.7%) 80 1.6%
Additional minimally sufﬁcient confounding subsets
MSS2¥: other children in household, crowding, inﬂuenza infection in
30 days before culture
81.2 (62.9–90.4%) 35.6 (8.3–61.7%) 76 3.9%
MSS3¥: caregiver education, crowding, inﬂuenza infection in 30 days
before culture, prenatal care utilization, recent immigrant
neighborhood
83.1 (55.1–93.6%) 39.2 (6.5–65.3%) 52 2.0%
MSS4¥: caregiver education, inﬂuenza vaccination in the year before
culture, prenatal care utilization, recent immigrant neighborhood
82.4 (55.3–93.0%) 35.2 (13.6–63.0%) 54 2.7%
¥ All MSSs included adjustment for: matching factors (age and zip code), asthma, breastfeeding, underlying condition, daycare attendance, household income, insurance type
at culture, race/ethnicity, and smoking exposure. Additional variables included in each subset indicated in table.
a PCV13 ¼ 13-valent pneumococcal conjugate vaccine; NVT ¼ non-vaccine types; MSS ¼ Minimally Sufﬁcient confounding Subset.
b All models include adjustment for the matching variables, age and zip code. MSS1 was considered the primary subset due to less missing data (most discordant pairs
retained).
c Because this is a conditional (matched) analysis, only matched sets which have discordant vaccination status (i.e., vaccinated case/unvaccinated control[s] or un-
vaccinated case/vaccinated control[s]) contribute to the analysis.
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cases and enrolled controls, which takes into account both zip code
matching and our ability to locate and enroll controls. In this ana-
lysis, we found that enrolled cases were slightly less afﬂuent than
enrolled controls. This may be because parents of cases were easier
to locate (medical records from the IPD episode provide more cur-
rent contact information) and had an incentive to participate (their
child recently had a major illness), and therefore enrolled cases may
have been more representative of all eligible cases whereas enrolled
controls may have represented only the most afﬂuent of eligible
controls who were successfully located and contacted and gave
consent for participation.
Differences in both comparisons were smaller when census
tracts were compared as opposed to individual-level data (either
from the parent interview or birth certiﬁcates). This likely reﬂects
the fact that census tract is an ecologic measure and thus represents
the average for a geographic area, rather than individual differences.
Additionally, there was overlap in census tracts, blunting the dif-
ferences between groups.
Adjustment for the primary minimally sufﬁcient confounder
subset resulted in little change in the vaccine effectiveness point
estimate (1.6% absolute change). Similarly, none of the vaccine ef-
fectiveness point estimates from the additional confounder subsets
identiﬁed reached the 5% absolute change we decided a priori to be
meaningful. This suggests that our original (unadjusted except for
the matching factors) estimate of vaccine effectiveness was not
substantially biased – and therefore that traditional zip code
matching was adequate for control of individual-level SES. Less than
expected confounding by SES may also be due to the success of the
Vaccines for Children program, which has operated since 1994 and
has reduced immunization coverage disparities in many routine
childhood vaccines (Whitney, Zhou, Singleton, & Schuchat, 2014).
Our study had limitations. We were not able to conduct inter-
views with unenrolled controls and had some missing data even
for those children whose parents were interviewed (e.g., for
household income) and therefore had to rely on data from geo-
coding and birth certiﬁcates to assess SES. Census tracts, while
more granular than zip codes, still provide only a group-level es-
timate of SES. Census tract income, for example, may not be an
adequate proxy for individual income and may be simultaneouslymeasuring the effect of low individual income and living in a
poorer neighborhood. Birth certiﬁcates, meanwhile, provide in-
dividual-level information, but their accuracy can vary by state
(Vinikoor, Messer, Laraia, & Kaufman, 2010; Northam and Knapp,
2006; Zollinger, Przybylski, & Gamache, 2006). Additionally, birth
certiﬁcate variables were not available for cases born outside the
state where they lived at the time of their IPD episode. While more
information was available for enrolled children, data from parent
interviews (i.e., behavioral risk factors) could be subject to recall
bias. We attempted to mitigate this by using measurements less
prone to poor recall (e.g., any smoking exposure instead of number
of cigarettes per day), but this could potentially result in other
forms of misclassiﬁcation. Finally, control-children who moved
from the ABCs catchment area between birth and their matched
case-child's culture date were not included. It is not known what
percentage of controls who could not be contacted had moved out
of the catchment area.
Our study had a number of strengths, including multiple
measures of SES at both the neighborhood- and individual-level
from the parent/guardian, birth certiﬁcate, and census tract. Be-
cause we had access to SES information on unenrolled controls, we
were able to assess both the theoretical use of zip code as a proxy
for individual SES, as well as effects of selection methods on the
real world study population. And while birth certiﬁcates and
geocoding may not be the ideal way to estimate individual SES,
they provide more information on eligible children than is usually
available to researchers, especially in such a large surveillance
system. Such data can provide insight into the study population
and how selection may affect internal validity, as well as poten-
tially helping identify SES-related risk factors for disease.
In summary, we found that, despite some differences between
cases and controls, zip code matching achieved its intended pur-
pose and our estimated vaccine effectiveness is internally valid
with respect to individual-SES. Future research could focus on
understanding the principal components underlying enrollment
and improving ways to locate and contact eligible children.
Our results should be broadly generalizable to other vaccine ef-
fectiveness studies in the US, as well as studies of other health
outcomes utilizing similar control identiﬁcation and participant
enrollment methods.
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